The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review

A Vitiello, M Sabbatucci, A Silenzi, A Capuano… - Respiratory …, 2023 - Springer
Several risk factors for Coronavirus-2019 (COVID-19) disease have been highlighted in
clinical evidence. Among the various risk factors are advanced age, metabolic illness such …

The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review

NM Vaselli, D Hungerford, B Shenton, A Khashkhusha… - PloS one, 2021 - journals.plos.org
Background A year following the onset of the COVID-19 pandemic, new infections and
deaths continue to increase in Europe. Serological studies, through providing evidence of …

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation

V Bezzerri, V Gentili, M Api, A Finotti, C Papi… - Nature …, 2023 - nature.com
As an inherited disorder characterized by severe pulmonary disease, cystic fibrosis could be
considered a comorbidity for coronavirus disease 2019. Instead, current clinical evidence …

SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020

C Colombo, G Alicandro, V Daccó, V Gagliano… - PLoS …, 2021 - journals.plos.org
Objective To describe the symptoms and clinical course of SARS-CoV-2 infection in patients
with cystic fibrosis (CF). Methods We carried out a prospective multicentre cohort study …

Epidemiological profile of hospitalized patients with cystic fibrosis in Brazil due to severe acute respiratory infection during the COVID-19 pandemic and a systematic …

LS Marques, MN Boschiero, NMS Sansone… - Healthcare, 2023 - mdpi.com
Since the onset of the coronavirus disease, COVID-19 pandemic, concern arose for those
who might be at higher risk of a worse COVID-19 prognosis, such as those with cystic …

COVID-19 outcomes in people with cystic fibrosis

PR Burgel, C Goss - Current opinion in pulmonary medicine, 2021 - journals.lww.com
COVID-19 outcomes in people with cystic fibrosis : Current Opinion in Pulmonary Medicine
COVID-19 outcomes in people with cystic fibrosis : Current Opinion in Pulmonary Medicine Log …

SARS-CoV-2 infection in patients with cystic fibrosis: what we know so far

C Biondo, A Midiri, E Gerace, S Zummo, G Mancuso - Life, 2022 - mdpi.com
Respiratory infections are the most common and most frequent diseases, especially in
children and the elderly, characterized by a clear seasonality and with an incidence that …

The impact of COVID-19 in cystic fibrosis

PA Flume, L Saiman, B Marshall - Archivos de …, 2021 - pmc.ncbi.nlm.nih.gov
From the moment the COVID-19 pandemic was declared in March 2020, there was palpable
fear of the potential impact on the cystic fibrosis (CF) population. Not only were there reports …

[HTML][HTML] The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York

JL Simonson, C Esposito, T Frantzen… - Journal of Cystic …, 2022 - Elsevier
Background People with cystic fibrosis (pwCF) may be at risk of complications from COVID-
19 but the impact of COVID-19 on pwCF remains unknown. Methods We conducted a …

Risk factors for SARS-CoV-2 infection and severe COVID-19 in unvaccinated solid organ transplant recipients

C Vrij, K Bogaerts, P Vermeersch, K Lagrou… - Scientific Reports, 2024 - nature.com
The role of immunosuppressive therapy on SARS-CoV-2 infection risk and COVID-19
severity remains unclear in unvaccinated solid organ transplant recipients. We included …